November is Eye Donation Month, a time to raise awareness about the life-changing impact of cornea donation. It's also a time ...

Delhi's eyes are under siege from pollution and relentless screen time, leading to a surge in dry eye disease. Smog irritates, while reduced blinking ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby ...

Many eye banks won't accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail.

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions.

Glaukos Corp. today announced it received FDA approval for Epioxa, an eye therapy made to stop the progression of keratoconus.

Heart disease continues to stand as the No. 1 cause of death in the United States. Coronary heart disease, the most common type of heart disease in the U.S., was responsible for the deaths of nearly ...

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over a third of the global population and is linked to serious health problems. A new study has revealed that high blood ...

DONE TO STOP IT. USUALLY THIS TIME OF YEAR THEY WOULD BE FULL OF LEAVES. WE COULDN’T SEE THROUGH THE CANOPY, BUT TAKE A WALK THROUGH RAVENSWOOD PARK IN GLOUCESTER AND YOU’LL SEE A PROBLEM AS CLEAR AS ...

Before a heart attack, stroke or other cardiovascular disease hit, there are almost always warning signs, according to a new study. Those warning signs are well-known cardiovascular disease risk ...